Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
26.64
+0.34 (1.29%)
At close: Jan 21, 2025, 4:00 PM
26.66
+0.02 (0.08%)
After-hours: Jan 21, 2025, 7:59 PM EST
Pfizer Revenue
Pfizer had revenue of $17.70B in the quarter ending September 29, 2024, with 31.20% growth. This brings the company's revenue in the last twelve months to $59.38B, down -14.29% year-over-year. In the year 2023, Pfizer had annual revenue of $58.50B, down -41.70%.
Revenue (ttm)
$59.38B
Revenue Growth
-14.29%
P/S Ratio
2.54
Revenue / Employee
$674,716
Employees
88,000
Market Cap
150.97B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 58.50B | -41.83B | -41.70% |
Dec 31, 2022 | 100.33B | 19.04B | 23.43% |
Dec 31, 2021 | 81.29B | 39.64B | 95.16% |
Dec 31, 2020 | 41.65B | 746.00M | 1.82% |
Dec 31, 2019 | 40.91B | 80.00M | 0.20% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 87.70B |
Merck & Co. | 63.17B |
AbbVie | 55.53B |
AstraZeneca | 51.21B |
Novartis AG | 49.94B |
Thermo Fisher Scientific | 42.37B |
Abbott Laboratories | 41.22B |
PFE News
- 11 hours ago - Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last? - CNBC
- 19 hours ago - Rose's Income Garden Portfolio Revealed: Yield 6.2%/Defensive Sector Winners - Seeking Alpha
- 2 days ago - High-Yield Heroes - 3 Of The S&P 500's Biggest Payers - Seeking Alpha
- 3 days ago - 7 Stocks I'm Buying Amid This Goldilocks (For Now) Economy - Seeking Alpha
- 4 days ago - Depo-Provera Contraceptive Manufacturer Pfizer Target of Consumer Lawsuit, Brain Tumors Linked to Use, According to Law Firm FeganScott - GlobeNewsWire
- 4 days ago - 3 Upcoming Dividend Increases - Seeking Alpha
- 6 days ago - What To Expect From PFE Stock In 2025? - Forbes
- 6 days ago - Vaxcyte Aims To Outshine Pfizer With Bold VAX-31 Strategy - Seeking Alpha